These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 15579109

  • 1. In silico methods for predicting ligand binding determinants of cytochromes P450.
    de Groot MJ, Kirton SB, Sutcliffe MJ.
    Curr Top Med Chem; 2004; 4(16):1803-24. PubMed ID: 15579109
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Toward Computational Understanding of Molecular Recognition in the Human Metabolizing Cytochrome P450s.
    Kontoyianni M, Lacy B.
    Curr Med Chem; 2018; 25(28):3353-3373. PubMed ID: 29484977
    [Abstract] [Full Text] [Related]

  • 5. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
    Dong D, Wu B, Chow D, Hu M.
    Drug Metab Rev; 2012 May; 44(2):192-208. PubMed ID: 22251142
    [Abstract] [Full Text] [Related]

  • 6. Pharmacophore modeling of cytochromes P450.
    de Groot MJ, Ekins S.
    Adv Drug Deliv Rev; 2002 Mar 31; 54(3):367-83. PubMed ID: 11922953
    [Abstract] [Full Text] [Related]

  • 7. Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity.
    Lewis DF, Ito Y.
    Xenobiotica; 2009 Aug 31; 39(8):625-35. PubMed ID: 19514836
    [Abstract] [Full Text] [Related]

  • 8. Combined three-dimensional quantitative structure-activity relationship analysis of cytochrome P450 2B6 substrates and protein homology modeling.
    Wang Q, Halpert JR.
    Drug Metab Dispos; 2002 Jan 31; 30(1):86-95. PubMed ID: 11744616
    [Abstract] [Full Text] [Related]

  • 9. Predicting the cytochrome P450 mediated metabolism of xenobiotics.
    Korzekwa KR, Jones JP.
    Pharmacogenetics; 1993 Feb 31; 3(1):1-18. PubMed ID: 8485584
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative modelling of cytochromes P450.
    Kirton SB, Baxter CA, Sutcliffe MJ.
    Adv Drug Deliv Rev; 2002 Mar 31; 54(3):385-406. PubMed ID: 11922954
    [Abstract] [Full Text] [Related]

  • 12. In silico prediction of cytochrome P450-mediated site of metabolism (SOM).
    Liu X, Shen Q, Li J, Li S, Luo C, Zhu W, Luo X, Zheng M, Jiang H.
    Protein Pept Lett; 2013 Mar 31; 20(3):279-89. PubMed ID: 22591483
    [Abstract] [Full Text] [Related]

  • 13. Compound lipophilicity for substrate binding to human P450s in drug metabolism.
    Lewis DF, Jacobs MN, Dickins M.
    Drug Discov Today; 2004 Jun 15; 9(12):530-7. PubMed ID: 15183161
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Toward reduction in animal sacrifice for drugs: molecular modeling of Macaca fascicularis P450 2C20 for virtual screening of Homo sapiens P450 2C8 substrates.
    Rua F, Di Nardo G, Sadeghi SJ, Gilardi G.
    Biotechnol Appl Biochem; 2012 Jun 15; 59(6):479-89. PubMed ID: 23586958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.